Table 1.
Wk 2 < 0% Improved | Wk 2 < 10% Improved | Wk 2 < 20% Improved | |||||
---|---|---|---|---|---|---|---|
T20 NPV | TF NPV | T20 NPV | TF NPV | T20 NPV | TF NPV | ||
IDS-SR | 50%* | 97.0 | 84.8 | 95.1 | 76.8 | 93.1 | 72.3 |
34%** | 97.0 | 69.7 | 91.5 | 61.0 | 80.8 | 54.6 | |
PHQ-9 | 50%* | 90.4 | 65.9 | 90.4 | 62.7 | 85.5 | 58.9 |
47%** | 90.2 | 65.9 | 90.4 | 61.4 | 84.7 | 58.1 |
NPVs based on % improvement at Week 2, corresponding with completion of 10 TMS sessions. All NPVs reported in %. For all parameters tested, NPVs were lower when overall outcome was determined using final scores vs. those collected at week 4 (treatment 20). T20 = Treatment session #20; TF = Final treatment session;
standard 50 % improvement criterion applied to define response;
data- driven % improvement criterion for defining response based on Kernel Density Estimate (see supplemental data figures 1 and 2)